The goal of this clinical trial is to learn if topical Cyclosporine 1% works to treat severe allergic ocular surface inflammation in pediatric population. The study will evaluate the efficacy and safety of topical Cyclosporine 1%.
The main questions it aims to answer are:
Does topical Cyclosporine 1% lower the number of times participants need to use a rescue steroid? What medical problems do participants have when taking topical Cyclosporine 1%?
Participants will:
Take topical Cyclosporine 1% every day for months. Visit the clinic once every 2-6 weeks for checkups and tests. Keep a diary of their symptoms and the number of times they use a rescue medication. spelling errors/typos and update as appropriate.
Inclusion Criteria:
Exclusion Criteria:
luhyoun21c@gmail.com+3614591500
Topical 1% cyclosporin applied for treatment Chronic ocular allergic inflammation
Blepharokeratoconjunctivitis patients who have accompaining blepharitis and ocular surface inflammation as well
Budapest, Pest County 1085, Hungary
veres.amarilla@semmelweis.hu003614591500
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes
Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis